Chinese herbal treatment for COVID-19 goes to trial in the US

A Chinese herbal formula used to treat coronavirus patients in China is undergoing clinical trials in the US for possible approval for people with mild-to-moderate symptoms of the viral disease.

Qingfei Paidu, most commonly called QFPD, is a 21-herb formula whose name literally means “lung cleansing and detoxification.” 

The US Food and Drug Administration approved a “double-blind randomized control” trial of the treatment in June. Such a trial, considered the gold standard of epidemiologic studies, is one where neither the participant nor the researcher knows whether the patient is receiving an experimental treatment or a placebo.

Read more:

Acupuncture Times Logo

Hi there!

Sign up to receive the latest research in acupuncture, cupping, moxibustion, Chinese herbal medicine and more, once a week.

About Attilio

Doctor of Chinese medicine, acupuncture expert and author of My Fertility Guide and My Pregnancy Guide.

Check Also

Pub Med

Chinese herbal medicine reduces the severity of COVID-19

Background: The coronavirus disease 2019 (COVID-19) is still a pandemic globally, about 80% of patients infected …